Metropolis Healthcare Share Price
582.95-2.55 (-0.44%)
+13.74% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
FORTISNSE
ASTERDMNSE
MEDANTANSE
NHNSE
KIMSNSE
LALPATHLABNSE
VIJAYANSE
METROPOLISNSE
Metropolis Healthcare Share Price
582.95-2.55 (-0.44%)
+13.74% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 12% | 11% | 13% | 24% |
| 10% | 1% | 10% | 31% |
| - | -5% | 18% | 12% |
| 23% | 16% | 13% | 14% |
Peer Comparison
Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
FORTIS
ASTERDM
MEDANTA
NH
KIMS
LALPATHLAB
VIJAYA
METROPOLIS
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,888.5 | ₹130273 Cr | 62.35 | 40.39 | 207.67 | ₹1942 Cr |
| 1,046 | ₹102446 Cr | 70.32 | 3.31 | 19.84 | ₹1442 Cr |
| 742.5 | ₹100021 Cr | 112.09 | 1.96 | 11.95 | ₹892 Cr |
| 877.35 | ₹67267 Cr | 64.19 | 3.53 | 20.1 | ₹1042 Cr |
| 768.65 | ₹66295 Cr | 208.03 | 0.31 | 6.76 | ₹388 Cr |
| 1,506.2 | ₹40209 Cr | 72.3 | 5.91 | 29.85 | ₹556 Cr |
| 1,877.7 | ₹39270 Cr | 48.12 | 10.14 | 65.36 | ₹806 Cr |
| 802 | ₹33529 Cr | 164.12 | 1.04 | 12.74 | ₹241 Cr |
| 1,961.3 | ₹32271 Cr | 59.55 | 10.11 | 42.51 | ₹505 Cr |
| 1,526.5 | ₹16149 Cr | 86.13 | 5.16 | 27.53 | ₹173 Cr |
| 582.55 | ₹12153 Cr | 60.27 | 2.73 | 16.24 | ₹190 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹41 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| ₹11 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹12 Cr | ₹9 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹5 L | ₹0 | ₹0 |
| ₹1461 Cr | ₹1313 Cr | ₹1078 Cr | ₹971 Cr | ₹864 Cr | ₹688 Cr | ₹511 Cr | ₹406 Cr | ₹404 Cr | ₹314 Cr | ₹255 Cr | ₹351 Cr |
| ₹1461 Cr | ₹1313 Cr | ₹1078 Cr | ₹971 Cr | ₹864 Cr | ₹688 Cr | ₹511 Cr | ₹406 Cr | ₹404 Cr | ₹314 Cr | ₹255 Cr | ₹351 Cr |
| ₹1513 Cr | ₹1331 Cr | ₹1096 Cr | ₹988 Cr | ₹886 Cr | ₹707 Cr | ₹523 Cr | ₹419 Cr | ₹415 Cr | ₹323 Cr | ₹265 Cr | ₹361 Cr |
| ₹11 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹14 Cr | ₹21 Cr | ₹20 Cr | ₹23 Cr |
| ₹0 | ₹5 Cr | ₹0 | ₹29 Cr | ₹159 Cr | ₹0 | ₹0 | ₹4 L | ₹20 L | ₹36 L | ₹46 L | ₹4 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹3 Cr | ₹4 Cr |
| ₹98 Cr | ₹91 Cr | ₹67 Cr | ₹71 Cr | ₹77 Cr | -₹13 Cr | -₹12 Cr | -₹76 L | -₹85 L | ₹4 Cr | -₹5 Cr | -₹2 Cr |
| ₹140 Cr | ₹107 Cr | ₹119 Cr | ₹126 Cr | ₹84 Cr | ₹80 Cr | ₹50 Cr | ₹2 Cr | ₹2 Cr | ₹9 Cr | ₹0 | ₹84 L |
| ₹191 Cr | ₹240 Cr | ₹187 Cr | ₹191 Cr | ₹174 Cr | ₹44 Cr | ₹156 Cr | ₹140 Cr | ₹146 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| ₹429 Cr | ₹444 Cr | ₹373 Cr | ₹417 Cr | ₹493 Cr | ₹111 Cr | ₹195 Cr | ₹142 Cr | ₹148 Cr | ₹16 Cr | ₹1 Cr | ₹10 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹129 Cr | ₹126 Cr | ₹99 Cr | ₹94 Cr | ₹103 Cr | ₹111 Cr | ₹85 Cr | ₹43 Cr | ₹35 Cr | ₹36 Cr | ₹38 Cr | ₹34 Cr |
| ₹125 Cr | ₹140 Cr | ₹120 Cr | ₹102 Cr | ₹84 Cr | ₹73 Cr | ₹74 Cr | ₹50 Cr | ₹42 Cr | ₹102 Cr | ₹38 Cr | ₹35 Cr |
| ₹19 Cr | ₹0 | ₹0 | ₹50 Cr | ₹100 Cr | ₹0 | ₹0 | ₹18 Cr | ₹37 L | ₹40 L | ₹19 L | ₹19 L |
| ₹298 Cr | ₹222 Cr | ₹56 Cr | ₹57 Cr | ₹77 Cr | ₹56 Cr | ₹51 Cr | ₹131 Cr | ₹155 Cr | ₹13 Cr | ₹28 Cr | ₹6 Cr |
| ₹571 Cr | ₹488 Cr | ₹275 Cr | ₹303 Cr | ₹364 Cr | ₹240 Cr | ₹210 Cr | ₹241 Cr | ₹233 Cr | ₹152 Cr | ₹105 Cr | ₹75 Cr |
| ₹2525 Cr | ₹2266 Cr | ₹1748 Cr | ₹1710 Cr | ₹1745 Cr | ₹1059 Cr | ₹930 Cr | ₹803 Cr | ₹810 Cr | ₹512 Cr | ₹391 Cr | ₹468 Cr |
| ₹10 Cr | ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹17 Cr | ₹17 Cr | ₹13 Cr | ₹14 Cr | ₹4 Cr | ₹0 | ₹74 L |
| ₹19 Cr | ₹14 Cr | ₹0 | ₹79 Cr | ₹259 Cr | ₹0 | ₹4 L | ₹18 Cr | ₹73 L | ₹93 L | ₹7 Cr | ₹14 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹2164 Cr | ₹1877 Cr | ₹1493 Cr | ₹1344 Cr | ₹1223 Cr | ₹438 Cr | ₹366 Cr | ₹271 Cr | ₹246 Cr | ₹220 Cr | ₹273 Cr | ₹260 Cr |
| ₹563 Cr | ₹430 Cr | ₹316 Cr | ₹224 Cr | ₹165 Cr | ₹95 Cr | ₹70 Cr | ₹58 Cr | ₹39 Cr | ₹17 Cr | ₹125 Cr | ₹107 Cr |
| ₹1601 Cr | ₹1447 Cr | ₹1177 Cr | ₹1121 Cr | ₹1059 Cr | ₹343 Cr | ₹296 Cr | ₹213 Cr | ₹207 Cr | ₹202 Cr | ₹148 Cr | ₹153 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹95 L | ₹56 L | ₹36 L |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹8 Cr | ₹2 Cr | ₹3 Cr |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹8 Cr | ₹2 Cr | ₹3 Cr |
| ₹215 Cr | ₹272 Cr | ₹219 Cr | ₹226 Cr | ₹207 Cr | ₹68 Cr | ₹179 Cr | ₹150 Cr | ₹149 Cr | ₹13 Cr | ₹16 Cr | ₹10 Cr |
| ₹1 Cr | ₹6 Cr | ₹5 Cr | ₹1 Cr | ₹16 Cr | ₹2 Cr | ₹12 Cr | ₹10 Cr | ₹9 Cr | ₹2 Cr | ₹4 L | ₹12 L |
| ₹1819 Cr | ₹1727 Cr | ₹1403 Cr | ₹1370 Cr | ₹1289 Cr | ₹414 Cr | ₹492 Cr | ₹381 Cr | ₹367 Cr | ₹227 Cr | ₹166 Cr | ₹167 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹141 Cr | ₹69 Cr | ₹53 Cr | ₹13 Cr | ₹14 Cr | ₹8 Cr | ₹13 Cr | ₹31 Cr | ₹100 Cr | ₹134 Cr | ₹79 Cr | ₹167 Cr |
| ₹45 Cr | ₹48 Cr | ₹39 Cr | ₹45 Cr | ₹51 Cr | ₹41 Cr | ₹24 Cr | ₹26 Cr | ₹21 Cr | ₹14 Cr | ₹18 Cr | ₹18 Cr |
| ₹170 Cr | ₹148 Cr | ₹126 Cr | ₹122 Cr | ₹135 Cr | ₹123 Cr | ₹128 Cr | ₹137 Cr | ₹101 Cr | ₹80 Cr | ₹77 Cr | ₹76 Cr |
| ₹62 Cr | ₹49 Cr | ₹71 Cr | ₹93 Cr | ₹167 Cr | ₹420 Cr | ₹210 Cr | ₹80 Cr | ₹60 Cr | ₹41 Cr | ₹43 Cr | ₹29 Cr |
| ₹13 Cr | ₹11 Cr | ₹7 Cr | ₹9 Cr | ₹10 Cr | ₹3 Cr | ₹5 Cr | ₹12 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr |
| ₹274 Cr | ₹215 Cr | ₹49 Cr | ₹58 Cr | ₹78 Cr | ₹50 Cr | ₹57 Cr | ₹135 Cr | ₹156 Cr | ₹12 Cr | ₹6 Cr | ₹9 Cr |
| ₹706 Cr | ₹540 Cr | ₹345 Cr | ₹341 Cr | ₹455 Cr | ₹645 Cr | ₹438 Cr | ₹422 Cr | ₹443 Cr | ₹285 Cr | ₹225 Cr | ₹302 Cr |
| ₹135 Cr | ₹52 Cr | ₹70 Cr | ₹38 Cr | ₹92 Cr | ₹405 Cr | ₹228 Cr | ₹180 Cr | ₹210 Cr | ₹133 Cr | ₹120 Cr | ₹227 Cr |
| ₹2525 Cr | ₹2266 Cr | ₹1748 Cr | ₹1710 Cr | ₹1745 Cr | ₹1059 Cr | ₹930 Cr | ₹803 Cr | ₹810 Cr | ₹512 Cr | ₹391 Cr | ₹468 Cr |
| ₹72 | ₹255 | ₹212 | ₹192 | ₹171 | ₹137 | ₹103 | ₹83 | ₹433 | ₹339 | ₹278 | ₹366 |
| ₹72 | ₹64 | ₹212 | ₹192 | ₹171 | ₹137 | ₹103 | ₹83 | ₹83 | ₹65 | ₹53 | ₹70 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Cash & Cash Equivalent of Subsidiaries under liquidations
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹259 Cr | ₹191 Cr | ₹175 Cr | ₹188 Cr | ₹293 Cr | ₹244 Cr | ₹169 Cr | ₹187 Cr | ₹164 Cr | ₹160 Cr | ₹128 Cr | ₹101 Cr |
| ₹190 Cr | ₹132 Cr | ₹121 Cr | ₹104 Cr | ₹59 Cr | ₹77 Cr | ₹83 Cr | ₹22 Cr | ₹21 Cr | -₹3 Cr | ₹9 Cr | ₹16 Cr |
| -₹53 Cr | -₹16 Cr | ₹5 Cr | ₹7 Cr | -₹16 Cr | -₹15 Cr | ₹28 Cr | -₹51 Cr | -₹23 Cr | -₹4 Cr | -₹3 Cr | -₹17 Cr |
| ₹396 Cr | ₹307 Cr | ₹301 Cr | ₹299 Cr | ₹336 Cr | ₹306 Cr | ₹279 Cr | ₹158 Cr | ₹162 Cr | ₹153 Cr | ₹134 Cr | ₹100 Cr |
| ₹351 Cr | ₹263 Cr | ₹264 Cr | ₹247 Cr | ₹253 Cr | ₹249 Cr | ₹215 Cr | ₹90 Cr | ₹104 Cr | ₹102 Cr | ₹88 Cr | ₹70 Cr |
| -₹223 Cr | -₹201 Cr | -₹89 Cr | ₹47 Cr | -₹738 Cr | ₹62 Cr | -₹105 Cr | ₹35 Cr | ₹2 Cr | -₹86 Cr | ₹91 Cr | -₹56 Cr |
| -₹115 Cr | -₹87 Cr | -₹181 Cr | -₹292 Cr | ₹163 Cr | -₹33 Cr | -₹55 Cr | -₹118 Cr | -₹87 Cr | -₹17 Cr | -₹166 Cr | -₹10 Cr |
| ₹12 Cr | -₹25 Cr | -₹7 Cr | ₹2 Cr | -₹322 Cr | ₹278 Cr | ₹55 Cr | ₹7 Cr | ₹19 Cr | -₹1 Cr | ₹13 Cr | ₹4 Cr |
| ₹39 Cr | ₹63 Cr | ₹69 Cr | ₹66 Cr | ₹387 Cr | ₹107 Cr | ₹51 Cr | ₹43 Cr | ₹26 Cr | ₹27 Cr | ₹24 Cr | ₹20 Cr |
| ₹57 L | ₹82 L | ₹0 | ₹0 | ₹3 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹78 L | ₹2 L | ₹0 | ₹0 |
| ₹2 Cr | ₹98 L | ₹33 L | ₹1 Cr | -₹1 Cr | ₹1 Cr | ₹96 L | ₹56 L | ₹23 L | -₹1 L | ₹0 | ₹0 |
| ₹55 Cr | ₹39 Cr | ₹63 Cr | ₹69 Cr | ₹66 Cr | ₹387 Cr | ₹107 Cr | ₹51 Cr | ₹43 Cr | ₹26 Cr | ₹36 Cr | ₹24 Cr |
Fundamental Ratios
Consolidated
Standalone
Metropolis Healthcare Share Price
582.95-2.55 (-0.44%)
+13.74% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 3 out of 9 oscillators
RSI
50.87Neutral
STOCH %K
50.25Neutral
MACD Level(12,26)
4.77Buy
Ultimate Oscillator
52.13Buy
Aroon Oscillator
-30.00Sell
BOP
-0.09Sell
CCI
-29.02Neutral
Williams %R
-49.75Neutral
Momentum
-8.95Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 moving averages
EMA 9
587.13Sell
SMA 9
586.32Sell
EMA 21
583.42Sell
SMA 21
585.60Sell
EMA 50
573.08Buy
SMA 50
575.20Buy
EMA 200
527.22Buy
SMA 200
513.89Buy
WMA 20
587.32Sell
Pivot
Pivot
Classic
Resistance 5
645.12
Resistance 4
630.67
Resistance 3
616.22
Resistance 2
601.77
Resistance 1
593.63
Pivot
587.32
Support 1
579.18
Support 2
572.87
Support 3
558.42
Support 4
543.97
Support 5
529.52
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Metropolis Healthcare Share Price
582.95-2.55 (-0.44%)
+13.74% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 48.86% | 48.87% | 48.88% | 48.89% | 48.89% | 48.89% |
| 11.03% | 10.43% | 11.68% | 12.52% | 12.83% | 15.29% |
| 2.44% | 2.52% | 2.51% | 2.41% | 2.59% | 3.88% |
| 32.67% | 33.28% | 32.22% | 30.69% | 29.81% | 26.42% |
| 5.00% | 4.90% | 4.71% | 5.49% | 5.88% | 5.52% |
Bulk & block deals
Name
Aditya Birla Sun Life Mutual Fund
Duru Shah Family Trust
Metz Advisory Llp
Aditya Birla Sun Life Mutual Fund
Morgan Stanley Asia Singapore Pte
Icici Prudential Mutual Fund
Metz Advisory Llp
Duru Shah Family Trust
Core Diagnostics (Mauritius) Private Limited
Goldman Sachs Bank Europese - Odi
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 11 Aug 2026 | Purchase | 59.16 Cr | ₹564 | 10.49 L | Bulk | 0.505655 | NSE |
| 11 Aug 2026 | Sell | 59.22 Cr | ₹564 | 10.50 L | Bulk | 0.506137 | NSE |
| 11 Aug 2026 | Sell | 59.22 Cr | ₹564 | 10.50 L | Bulk | 0.506137 | NSE |
| 11 Aug 2026 | Purchase | 59.16 Cr | ₹564 | 10.49 L | Block | 0.505655 | NSE |
| 11 Aug 2026 | Purchase | 29.64 Cr | ₹564 | 5.25 L | Block | 0.253309 | NSE |
| 11 Aug 2026 | Purchase | 29.64 Cr | ₹564 | 5.25 L | Block | 0.253309 | NSE |
| 11 Aug 2026 | Sell | 59.22 Cr | ₹564 | 10.50 L | Block | 0.506137 | NSE |
| 11 Aug 2026 | Sell | 59.22 Cr | ₹564 | 10.50 L | Block | 0.506137 | NSE |
| 04 Dec 2025 | Sell | 55.72 Cr | ₹1,905.11 | 2.92 L | Bulk | 0.140974 | BSE |
| 16 Oct 2025 | Purchase | 10.69 Cr | ₹1,944 | 55 K | Block | 0.026512 | NSE |
Insider trading & SAST
Client name
Duru Shah Family Trust & Pacs
Metz Advisory Llp & Pacs
Duru Shah Family Trust
Metz Advisory Llp
Jp Morgan Asset Management (Uk) Ltd & Others
Dr. Sushil Shah
Sushil Shah Family Trust
Sushil Shah Family Trust
Sushil Kanubhai Shah
Duru Shah Family Trust & Pacs
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Aug 2026 | Promoter | Disposal | 0.51 | 10.54 | 0 | — | 10.50 L | 11 Aug 2026 | Market | 2,18,68,740 | SAST | 29(2) | — |
| 31 Aug 2026 | Promoter | Disposal | 0.51 | 29.76 | 0 | — | 10.50 L | 11 Aug 2026 | Market | 6,17,14,864 | SAST | 29(2) | — |
| 13 Aug 2026 | Promoter Group | Disposal | 0.506298 | 10.54 | 59.22 Cr | ₹564 | 10.50 L | 11 Aug 2026 | Market Sale | 2,18,68,740 | Insider Trading | — | Equity |
| 13 Aug 2026 | Promoter | Disposal | 0.506298 | 29.76 | 59.22 Cr | ₹564 | 10.50 L | 11 Aug 2026 | Market Sale | 6,17,14,864 | Insider Trading | — | Equity |
| 17 Jul 2025 | Other | Disposal | 0.66 | 3.15 | 0 | — | 3.44 L | 27 Jun 2025 | Market | 16,33,658 | SAST | 29(2) | — |
| 26 Jun 2025 | Promoter | Disposal | 2.25 | — | 0 | — | 11.67 L | 29 May 2025 | Inter-se Transfer | — | SAST | 29(2) | — |
| 26 Jun 2025 | Promoter | Acquisition | 2.25 | 7.19 | 0 | — | 11.67 L | 29 May 2025 | Inter-se Transfer | 37,25,245 | SAST | 29(2) | — |
| 02 Jun 2025 | Promoter | Acquisition | 2.252925 | 7.19 | 0 | — | 11.67 L | 29 May 2025 | Inter-se Transfer | 37,25,245 | Insider Trading | — | Equity Shares |
| 02 Jun 2025 | Promoter & Director | Disposal | 2.252925 | 0 | 0 | — | 11.67 L | 29 May 2025 | Inter-se Transfer | 0 | Insider Trading | — | Equity Shares |
| 21 Apr 2025 | Promoter | Acquisition | 1.48 | 11.06 | 0 | — | 7.66 L | 26 Mar 2025 | Inter-se Transfer | 57,29,685 | SAST | 29(2) | — |
Metropolis Healthcare Share Price
582.95-2.55 (-0.44%)
+13.74% past 1 Year
Metropolis Healthcare Limited is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease
Corporate Actions
Date
Type
Details
Company details
Metropolis Healthcare Share Price
582.95-2.55 (-0.44%)
+13.74% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Metropolis Healthcare Share Price
582.95-2.55 (-0.44%)
+13.74% past 1 Year
News
Metropolis Healthcare subsidiary Mqspl partners with Medsource, stake rises to 54.90 percent
Equity
METROPOLIS
Metropolis Healthcare targets Rs 2,500 crore annual organic revenue in 3 years
Equity
METROPOLIS
Kotak maintains Add rating on Metropolis Healthcare with Rs 655 target
Equity
METROPOLIS
Metropolis Healthcare holds prices; inflation pass-through only when conditions improve
Equity
METROPOLIS
Metropolis Healthcare plans aggressive expansion of diagnostic centers in smaller towns
Equity
METROPOLIS
Metropolis Healthcare maintains steady Rs 65 crores capex guidance for FY
Equity
METROPOLIS
Metropolis Healthcare projects 100-150 bps EBITDA margin improvement in FY27
Equity
METROPOLIS
Metropolis Healthcare reiterates 14-15 percent revenue growth guidance for FY26
Equity
METROPOLIS
Metropolis Healthcare Q1 FY27 EBITDA rises with margin expansion YoY
Equity
METROPOLIS
Metropolis Healthcare posts strong Q1 revenue growth on robust diagnostic demand
Equity
METROPOLIS
Metropolis Healthcare Q1 profit rises strongly year-on-year on better performance
Equity
METROPOLIS
Metropolis Healthcare posts 16 percent YoY revenue growth in Q1 FY27
Equity
METROPOLIS
Metropolis Healthcare sets FY27 revenue growth goal after weak Q4 print
Equity
METROPOLIS
Metropolis Health. - Quaterly Results
Equity
METROPOLIS
Metropolis Healthcare Reports 23% YoY Revenue Growth in Q4 FY26, Network Expands Beyond 5000 Centers
Equity
METROPOLIS
Metropolis Healthcare reports higher Q4 EBITDA and stronger margin year on year
Equity
METROPOLIS
Metropolis Healthcare Q4 profit and revenue rise sharply on strong growth
Equity
METROPOLIS
Metropolis Health. reports Profit after tax of 43.26 Crores, in the March 2026 quarter
Equity
METROPOLIS
Metropolis Healthcare informs about allotment of bonus equity shares
Equity
METROPOLIS
Metropolis Health. - Quaterly Results
Equity
METROPOLIS

